Medical units that are not affected by bulk purchase need to consult relevant information to answer. According to years of study experience, if you can answer the medical units that are not affected by bulk purchase, you can get twice the result with half the effort. Here are some methods and experiences of medical units that are not affected by bulk purchase for your reference.
Medical units unaffected by large-scale procurement
Medical unit generally refers to medical service unit, which refers to companies that provide services to medical and health institutions and gain benefits from them, including medical devices, medicines, medical information, medical logistics, medical assistance and other companies. These companies have nothing to do with large purchases, so they are not affected by large purchases.
The following are some medical units that are not affected by large purchases:
_ _ Mindray Medical: the leading medical device in China, whose products cover life information and support, in vitro diagnosis, medical imaging and other fields.
_ _ Fan Jian Bio: a leading enterprise in chinese journal of blood purification, whose products cover hemoperfusion, hemodialysis, hemofiltration and other products.
_ _ Southern Micro-medicine: the leading enterprise of digestive tract endoscopic diagnosis and treatment equipment in China, whose products cover digestive tract endoscopic diagnosis and treatment equipment, stapler and other products.
_ _ Kangtai Medical: the leading high-end medical equipment in China, and its products cover anesthesia systems, ventilators, electrocardiographs and other high-end medical equipment.
_ _ Yuyue Medical: the leading enterprise of domestic household medical devices, whose products cover sphygmomanometer, stethoscope, atomizer and other household medical devices.
_ _ Wanbangde: A leading chemical enterprise in the field of cardiovascular and cerebrovascular diseases in China, whose products cover antihypertensive drugs, angina pectoris drugs, antithrombotic drugs and other products.
It should be noted that the above are only some pharmaceutical stocks that are not affected by large purchases, and the investment is risky. Investors should choose according to their own risk preferences and investment objectives.
Medical units not affected by centralized procurement
The pharmaceutical unit is not affected by centralized procurement. Here are some examples:
_ _ Wan Tai Bio: Its bivalent HPV vaccine is the only vaccine that can block HPV1618 infection and reduce the risk of cervical cancer, and signed a long-term supply agreement of 50 million tablets.
_ _ Pien Tze Huang: The company is a national medical insurance catalog, with 9 exclusive varieties, 4 approved by the State Food and Drug Administration and 53 approved by the State Food and Drug Administration, including 3 original drugs and 0/2 exclusive dosage forms/kloc.
_ _ Tiger Pharmaceuticals: GCP and GLP are necessary qualifications for drug research and development. Tiger medicine is one of the enterprises with these two qualifications in the industry, and has these two "double qualifications" certifications.
These are just some examples. Whether medical and pharmaceutical stocks are affected by centralized procurement depends on the specific situation of the company.
Which medical units are not affected by centralized procurement?
In medical units, the following companies may not be affected by centralized procurement:
_ _ Gushengtang: The number of Chinese medicine retail pharmacies in our company is 140, all of which are holding subsidiaries. This makes Gushengtang avoid the negotiation of centralized procurement policy of large-scale medical equipment in urban public hospitals by the National Medical Insurance Bureau.
_ _ Jianhui Information: This company mainly provides intelligent medical logistics services for hospitals, which does not belong to the category of national centralized procurement.
_ _ Xinlitai: The company mainly produces drugs and develops new indications to meet clinical needs. In addition, Xinlitai's medicines do not depend on centralized collection.
This information is for reference only, investment is risky, and decision-making needs to be cautious. Investors should make their own decisions according to their own conditions.
List of medical units not affected by centralized procurement
Among the pharmaceutical stocks that are not affected by centralized procurement, the following stocks may have investment value:
_ _ Huada Gene: Its holding company, Huada Medical, holds 565,438+0% of Firestone Yang Kang Technology (Beijing) Co., Ltd. The company has two major industries: super equipment and smart health care. At the same time, it also laid out the dual track of "regional wisdom medical association+reproductive medicine center", covering reproductive medicine, smart health care and other fields.
_ _ Antu Bio: The company focuses on the field of in vitro diagnosis, and its products cover infectious diseases, liver function, renal function, clinical chemistry, clinical tests and other categories, which can meet the diversified needs of hospital diagnostic reagents and instruments and are not directly linked to the centralized procurement policy.
_ _ Aohua Endoscope: Although there is no digestive tract endoscope in its product line, the company's endoscope product line has a complete layout, covering urinary, respiratory, digestive and other fields.
In addition, Mindray Medical, Mingde Bio, Panda Kaikai Medical, Aier Ophthalmology and Tongce Medical are often regarded by investors as pharmaceutical stocks that are not affected by centralized procurement. These companies have relatively high business independence and performance stability, and often win the bid in centralized procurement of public hospitals.
Please note that there are risks in the investment in the medical industry, so please do full research and analysis before investing.
Medical units not affected by centralized procurement
The medical industry is closely related to the centralized procurement policy. The following are some medical units that are not affected by centralized procurement or are less affected by centralized procurement:
_ _ Gushengtang: Our company is a medical institution focusing on traditional Chinese medicine medical services, with rich resources of traditional Chinese medicine and professional medical services, which is not affected by the centralized procurement policy.
_ _ Jianhui Information: This company is an enterprise focusing on medical information solutions. Its main business includes hospital information, clinical medical information and primary medical information, which has little to do with centralized procurement policy.
_ _ Weining Health: This company is an enterprise focusing on medical and health informatization, and its main business includes hospital informatization, clinical informatization and primary medical informatization, which has little to do with centralized procurement policy.
The above are some medical units that are not affected by centralized procurement or are less affected by centralized procurement, but please pay attention to investment risks and conduct full research and analysis.
The introduction of medical units that are not affected by large purchases ends here.